Literature DB >> 2869238

Treatment of experimental Legionnaires' disease by aerosol administration of rifampicin, ciprofloxacin, and erythromycin.

R B Fitzgeorge, A Baskerville, A S Featherstone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2869238     DOI： 10.1016/s0140-6736(86)92960-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill.

Authors:  M O'Doherty; S Thomas; C Page; C Bradbeer; T Nunan; N Bateman
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

Review 2.  Use of rifampin in nonstaphylococcal, nonmycobacterial disease.

Authors:  A B Morris; R B Brown; M Sands
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

3.  Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1.

Authors:  P Rajagopalan-Levasseur; E Dournon; G Dameron; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

4.  Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia.

Authors:  P M Girard; M Brun-Pascaud; R Farinotti; L Tamisier; S Kernbaum
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

5.  Pneumonia in pregnancy.

Authors:  M Maccato
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.